European Review for Medical and Pharmacological Sciences-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2096292, encodeId=90cc209629218, content=一个月了还在under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e0f5698970, createdName=ms9000000591668568, createdTime=Wed Oct 26 16:43:17 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188819, encodeId=577f1188819fd, content=请问杂志Under consideration要多久才变under review呢，还是一直这样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Fri Jan 28 14:17:01 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898537, encodeId=662589853e72, content=请问这个杂志有under review.的状态吗？还是说一直是under consideration呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=558a5381281, createdName=ms7000002088020020, createdTime=Wed Nov 11 18:48:07 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209381, encodeId=f9d41209381d9, content=Under consideration 10多天没有变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcf094033, createdName=qlh80, createdTime=Thu Apr 07 21:50:28 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109521, encodeId=cb81210952132, content=投稿尽量选择一些稳定的期刊！不然后续风险还得自己承担！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=101c5653809, createdName=ms5000001132160057, createdTime=Mon Jan 09 15:13:13 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098055, encodeId=20f8209805579, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一个月不到小修，被医院预警准备撤稿了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e16453257, createdName=ms3000000976128588, createdTime=Wed Nov 02 15:12:55 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213542, encodeId=c49a1213542c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：癌症;药理;调查研究 经验分享：感觉还是挺容易的，不过也得看文章方向，感觉他们喜欢药物作用研究的，从投稿到录用不到一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Fri Apr 22 23:09:34 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196162, encodeId=a41f119616221, content=杂志对语言要求还蛮高的，内容没给我啥意见，语言修了两次。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Tue Feb 22 17:51:28 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925339, encodeId=82f892533950, content=审稿速度:1.0 | 投稿命中率:100.0 | 版面费用:900.0 偏重的研究方向：生信 经验分享：10月初接收，接收后说付款后三个月内给proof，3个月后发邮件问，说安排在二月第一期上线，上线前会收到proof，现在二月第一期已经上线了，依然没有收到proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c5f31644024, createdName=TitanAtlas, createdTime=Thu Feb 18 20:01:38 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803157, encodeId=315480315e6e, content=内部消息。这个杂志马上要完蛋。大家都别投了。否则是赔了夫人又折兵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2591613307, createdName=hgsge, createdTime=Sat Jul 18 00:28:40 CST 2020, time=2020-07-18, status=1, ipAttribution=)]

2022-10-26 ms9000000591668568

一个月了还在under consideration

41 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096292, encodeId=90cc209629218, content=一个月了还在under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e0f5698970, createdName=ms9000000591668568, createdTime=Wed Oct 26 16:43:17 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188819, encodeId=577f1188819fd, content=请问杂志Under consideration要多久才变under review呢，还是一直这样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Fri Jan 28 14:17:01 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898537, encodeId=662589853e72, content=请问这个杂志有under review.的状态吗？还是说一直是under consideration呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=558a5381281, createdName=ms7000002088020020, createdTime=Wed Nov 11 18:48:07 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209381, encodeId=f9d41209381d9, content=Under consideration 10多天没有变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcf094033, createdName=qlh80, createdTime=Thu Apr 07 21:50:28 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109521, encodeId=cb81210952132, content=投稿尽量选择一些稳定的期刊！不然后续风险还得自己承担！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=101c5653809, createdName=ms5000001132160057, createdTime=Mon Jan 09 15:13:13 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098055, encodeId=20f8209805579, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一个月不到小修，被医院预警准备撤稿了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e16453257, createdName=ms3000000976128588, createdTime=Wed Nov 02 15:12:55 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213542, encodeId=c49a1213542c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：癌症;药理;调查研究 经验分享：感觉还是挺容易的，不过也得看文章方向，感觉他们喜欢药物作用研究的，从投稿到录用不到一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Fri Apr 22 23:09:34 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196162, encodeId=a41f119616221, content=杂志对语言要求还蛮高的，内容没给我啥意见，语言修了两次。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Tue Feb 22 17:51:28 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925339, encodeId=82f892533950, content=审稿速度:1.0 | 投稿命中率:100.0 | 版面费用:900.0 偏重的研究方向：生信 经验分享：10月初接收，接收后说付款后三个月内给proof，3个月后发邮件问，说安排在二月第一期上线，上线前会收到proof，现在二月第一期已经上线了，依然没有收到proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c5f31644024, createdName=TitanAtlas, createdTime=Thu Feb 18 20:01:38 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803157, encodeId=315480315e6e, content=内部消息。这个杂志马上要完蛋。大家都别投了。否则是赔了夫人又折兵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2591613307, createdName=hgsge, createdTime=Sat Jul 18 00:28:40 CST 2020, time=2020-07-18, status=1, ipAttribution=)]

2022-01-28 ms3000001949605315

请问杂志Under consideration要多久才变under review呢，还是一直这样呢

57 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096292, encodeId=90cc209629218, content=一个月了还在under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e0f5698970, createdName=ms9000000591668568, createdTime=Wed Oct 26 16:43:17 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188819, encodeId=577f1188819fd, content=请问杂志Under consideration要多久才变under review呢，还是一直这样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Fri Jan 28 14:17:01 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898537, encodeId=662589853e72, content=请问这个杂志有under review.的状态吗？还是说一直是under consideration呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=558a5381281, createdName=ms7000002088020020, createdTime=Wed Nov 11 18:48:07 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209381, encodeId=f9d41209381d9, content=Under consideration 10多天没有变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcf094033, createdName=qlh80, createdTime=Thu Apr 07 21:50:28 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109521, encodeId=cb81210952132, content=投稿尽量选择一些稳定的期刊！不然后续风险还得自己承担！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=101c5653809, createdName=ms5000001132160057, createdTime=Mon Jan 09 15:13:13 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098055, encodeId=20f8209805579, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一个月不到小修，被医院预警准备撤稿了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e16453257, createdName=ms3000000976128588, createdTime=Wed Nov 02 15:12:55 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213542, encodeId=c49a1213542c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：癌症;药理;调查研究 经验分享：感觉还是挺容易的，不过也得看文章方向，感觉他们喜欢药物作用研究的，从投稿到录用不到一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Fri Apr 22 23:09:34 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196162, encodeId=a41f119616221, content=杂志对语言要求还蛮高的，内容没给我啥意见，语言修了两次。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Tue Feb 22 17:51:28 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925339, encodeId=82f892533950, content=审稿速度:1.0 | 投稿命中率:100.0 | 版面费用:900.0 偏重的研究方向：生信 经验分享：10月初接收，接收后说付款后三个月内给proof，3个月后发邮件问，说安排在二月第一期上线，上线前会收到proof，现在二月第一期已经上线了，依然没有收到proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c5f31644024, createdName=TitanAtlas, createdTime=Thu Feb 18 20:01:38 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803157, encodeId=315480315e6e, content=内部消息。这个杂志马上要完蛋。大家都别投了。否则是赔了夫人又折兵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2591613307, createdName=hgsge, createdTime=Sat Jul 18 00:28:40 CST 2020, time=2020-07-18, status=1, ipAttribution=)]

2020-11-11 ms7000002088020020

请问这个杂志有under review.的状态吗？还是说一直是under consideration呢？

151 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096292, encodeId=90cc209629218, content=一个月了还在under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e0f5698970, createdName=ms9000000591668568, createdTime=Wed Oct 26 16:43:17 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188819, encodeId=577f1188819fd, content=请问杂志Under consideration要多久才变under review呢，还是一直这样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Fri Jan 28 14:17:01 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898537, encodeId=662589853e72, content=请问这个杂志有under review.的状态吗？还是说一直是under consideration呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=558a5381281, createdName=ms7000002088020020, createdTime=Wed Nov 11 18:48:07 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209381, encodeId=f9d41209381d9, content=Under consideration 10多天没有变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcf094033, createdName=qlh80, createdTime=Thu Apr 07 21:50:28 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109521, encodeId=cb81210952132, content=投稿尽量选择一些稳定的期刊！不然后续风险还得自己承担！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=101c5653809, createdName=ms5000001132160057, createdTime=Mon Jan 09 15:13:13 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098055, encodeId=20f8209805579, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一个月不到小修，被医院预警准备撤稿了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e16453257, createdName=ms3000000976128588, createdTime=Wed Nov 02 15:12:55 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213542, encodeId=c49a1213542c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：癌症;药理;调查研究 经验分享：感觉还是挺容易的，不过也得看文章方向，感觉他们喜欢药物作用研究的，从投稿到录用不到一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Fri Apr 22 23:09:34 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196162, encodeId=a41f119616221, content=杂志对语言要求还蛮高的，内容没给我啥意见，语言修了两次。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Tue Feb 22 17:51:28 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925339, encodeId=82f892533950, content=审稿速度:1.0 | 投稿命中率:100.0 | 版面费用:900.0 偏重的研究方向：生信 经验分享：10月初接收，接收后说付款后三个月内给proof，3个月后发邮件问，说安排在二月第一期上线，上线前会收到proof，现在二月第一期已经上线了，依然没有收到proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c5f31644024, createdName=TitanAtlas, createdTime=Thu Feb 18 20:01:38 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803157, encodeId=315480315e6e, content=内部消息。这个杂志马上要完蛋。大家都别投了。否则是赔了夫人又折兵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2591613307, createdName=hgsge, createdTime=Sat Jul 18 00:28:40 CST 2020, time=2020-07-18, status=1, ipAttribution=)]

2022-04-07 qlh80

Under consideration 10多天没有变化

63 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096292, encodeId=90cc209629218, content=一个月了还在under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e0f5698970, createdName=ms9000000591668568, createdTime=Wed Oct 26 16:43:17 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188819, encodeId=577f1188819fd, content=请问杂志Under consideration要多久才变under review呢，还是一直这样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Fri Jan 28 14:17:01 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898537, encodeId=662589853e72, content=请问这个杂志有under review.的状态吗？还是说一直是under consideration呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=558a5381281, createdName=ms7000002088020020, createdTime=Wed Nov 11 18:48:07 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209381, encodeId=f9d41209381d9, content=Under consideration 10多天没有变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcf094033, createdName=qlh80, createdTime=Thu Apr 07 21:50:28 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109521, encodeId=cb81210952132, content=投稿尽量选择一些稳定的期刊！不然后续风险还得自己承担！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=101c5653809, createdName=ms5000001132160057, createdTime=Mon Jan 09 15:13:13 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098055, encodeId=20f8209805579, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一个月不到小修，被医院预警准备撤稿了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e16453257, createdName=ms3000000976128588, createdTime=Wed Nov 02 15:12:55 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213542, encodeId=c49a1213542c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：癌症;药理;调查研究 经验分享：感觉还是挺容易的，不过也得看文章方向，感觉他们喜欢药物作用研究的，从投稿到录用不到一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Fri Apr 22 23:09:34 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196162, encodeId=a41f119616221, content=杂志对语言要求还蛮高的，内容没给我啥意见，语言修了两次。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Tue Feb 22 17:51:28 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925339, encodeId=82f892533950, content=审稿速度:1.0 | 投稿命中率:100.0 | 版面费用:900.0 偏重的研究方向：生信 经验分享：10月初接收，接收后说付款后三个月内给proof，3个月后发邮件问，说安排在二月第一期上线，上线前会收到proof，现在二月第一期已经上线了，依然没有收到proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c5f31644024, createdName=TitanAtlas, createdTime=Thu Feb 18 20:01:38 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803157, encodeId=315480315e6e, content=内部消息。这个杂志马上要完蛋。大家都别投了。否则是赔了夫人又折兵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2591613307, createdName=hgsge, createdTime=Sat Jul 18 00:28:40 CST 2020, time=2020-07-18, status=1, ipAttribution=)]

2023-01-09 ms5000001132160057

投稿尽量选择一些稳定的期刊！不然后续风险还得自己承担！

36 0

[GetPortalCommentsPageByObjectIdResponse(id=2096292, encodeId=90cc209629218, content=一个月了还在under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e0f5698970, createdName=ms9000000591668568, createdTime=Wed Oct 26 16:43:17 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188819, encodeId=577f1188819fd, content=请问杂志Under consideration要多久才变under review呢，还是一直这样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Fri Jan 28 14:17:01 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898537, encodeId=662589853e72, content=请问这个杂志有under review.的状态吗？还是说一直是under consideration呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=558a5381281, createdName=ms7000002088020020, createdTime=Wed Nov 11 18:48:07 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209381, encodeId=f9d41209381d9, content=Under consideration 10多天没有变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcf094033, createdName=qlh80, createdTime=Thu Apr 07 21:50:28 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109521, encodeId=cb81210952132, content=投稿尽量选择一些稳定的期刊！不然后续风险还得自己承担！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=101c5653809, createdName=ms5000001132160057, createdTime=Mon Jan 09 15:13:13 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098055, encodeId=20f8209805579, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一个月不到小修，被医院预警准备撤稿了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e16453257, createdName=ms3000000976128588, createdTime=Wed Nov 02 15:12:55 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213542, encodeId=c49a1213542c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：癌症;药理;调查研究 经验分享：感觉还是挺容易的，不过也得看文章方向，感觉他们喜欢药物作用研究的，从投稿到录用不到一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Fri Apr 22 23:09:34 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196162, encodeId=a41f119616221, content=杂志对语言要求还蛮高的，内容没给我啥意见，语言修了两次。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Tue Feb 22 17:51:28 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925339, encodeId=82f892533950, content=审稿速度:1.0 | 投稿命中率:100.0 | 版面费用:900.0 偏重的研究方向：生信 经验分享：10月初接收，接收后说付款后三个月内给proof，3个月后发邮件问，说安排在二月第一期上线，上线前会收到proof，现在二月第一期已经上线了，依然没有收到proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c5f31644024, createdName=TitanAtlas, createdTime=Thu Feb 18 20:01:38 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803157, encodeId=315480315e6e, content=内部消息。这个杂志马上要完蛋。大家都别投了。否则是赔了夫人又折兵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2591613307, createdName=hgsge, createdTime=Sat Jul 18 00:28:40 CST 2020, time=2020-07-18, status=1, ipAttribution=)]

2022-11-02 ms3000000976128588

审稿速度:1.0 | 投稿命中率:75.0
经验分享：一个月不到小修，被医院预警准备撤稿了。。。

40 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096292, encodeId=90cc209629218, content=一个月了还在under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e0f5698970, createdName=ms9000000591668568, createdTime=Wed Oct 26 16:43:17 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188819, encodeId=577f1188819fd, content=请问杂志Under consideration要多久才变under review呢，还是一直这样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Fri Jan 28 14:17:01 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898537, encodeId=662589853e72, content=请问这个杂志有under review.的状态吗？还是说一直是under consideration呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=558a5381281, createdName=ms7000002088020020, createdTime=Wed Nov 11 18:48:07 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209381, encodeId=f9d41209381d9, content=Under consideration 10多天没有变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcf094033, createdName=qlh80, createdTime=Thu Apr 07 21:50:28 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109521, encodeId=cb81210952132, content=投稿尽量选择一些稳定的期刊！不然后续风险还得自己承担！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=101c5653809, createdName=ms5000001132160057, createdTime=Mon Jan 09 15:13:13 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098055, encodeId=20f8209805579, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一个月不到小修，被医院预警准备撤稿了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e16453257, createdName=ms3000000976128588, createdTime=Wed Nov 02 15:12:55 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213542, encodeId=c49a1213542c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：癌症;药理;调查研究 经验分享：感觉还是挺容易的，不过也得看文章方向，感觉他们喜欢药物作用研究的，从投稿到录用不到一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Fri Apr 22 23:09:34 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196162, encodeId=a41f119616221, content=杂志对语言要求还蛮高的，内容没给我啥意见，语言修了两次。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Tue Feb 22 17:51:28 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925339, encodeId=82f892533950, content=审稿速度:1.0 | 投稿命中率:100.0 | 版面费用:900.0 偏重的研究方向：生信 经验分享：10月初接收，接收后说付款后三个月内给proof，3个月后发邮件问，说安排在二月第一期上线，上线前会收到proof，现在二月第一期已经上线了，依然没有收到proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c5f31644024, createdName=TitanAtlas, createdTime=Thu Feb 18 20:01:38 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803157, encodeId=315480315e6e, content=内部消息。这个杂志马上要完蛋。大家都别投了。否则是赔了夫人又折兵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2591613307, createdName=hgsge, createdTime=Sat Jul 18 00:28:40 CST 2020, time=2020-07-18, status=1, ipAttribution=)]

2022-04-22 ms7000000507856696

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：癌症;药理;调查研究
经验分享：感觉还是挺容易的，不过也得看文章方向，感觉他们喜欢药物作用研究的，从投稿到录用不到一个月

58 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096292, encodeId=90cc209629218, content=一个月了还在under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e0f5698970, createdName=ms9000000591668568, createdTime=Wed Oct 26 16:43:17 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188819, encodeId=577f1188819fd, content=请问杂志Under consideration要多久才变under review呢，还是一直这样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Fri Jan 28 14:17:01 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898537, encodeId=662589853e72, content=请问这个杂志有under review.的状态吗？还是说一直是under consideration呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=558a5381281, createdName=ms7000002088020020, createdTime=Wed Nov 11 18:48:07 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209381, encodeId=f9d41209381d9, content=Under consideration 10多天没有变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcf094033, createdName=qlh80, createdTime=Thu Apr 07 21:50:28 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109521, encodeId=cb81210952132, content=投稿尽量选择一些稳定的期刊！不然后续风险还得自己承担！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=101c5653809, createdName=ms5000001132160057, createdTime=Mon Jan 09 15:13:13 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098055, encodeId=20f8209805579, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一个月不到小修，被医院预警准备撤稿了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e16453257, createdName=ms3000000976128588, createdTime=Wed Nov 02 15:12:55 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213542, encodeId=c49a1213542c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：癌症;药理;调查研究 经验分享：感觉还是挺容易的，不过也得看文章方向，感觉他们喜欢药物作用研究的，从投稿到录用不到一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Fri Apr 22 23:09:34 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196162, encodeId=a41f119616221, content=杂志对语言要求还蛮高的，内容没给我啥意见，语言修了两次。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Tue Feb 22 17:51:28 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925339, encodeId=82f892533950, content=审稿速度:1.0 | 投稿命中率:100.0 | 版面费用:900.0 偏重的研究方向：生信 经验分享：10月初接收，接收后说付款后三个月内给proof，3个月后发邮件问，说安排在二月第一期上线，上线前会收到proof，现在二月第一期已经上线了，依然没有收到proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c5f31644024, createdName=TitanAtlas, createdTime=Thu Feb 18 20:01:38 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803157, encodeId=315480315e6e, content=内部消息。这个杂志马上要完蛋。大家都别投了。否则是赔了夫人又折兵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2591613307, createdName=hgsge, createdTime=Sat Jul 18 00:28:40 CST 2020, time=2020-07-18, status=1, ipAttribution=)]

2022-02-22 ms3000001949605315

杂志对语言要求还蛮高的，内容没给我啥意见，语言修了两次。。。

55 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096292, encodeId=90cc209629218, content=一个月了还在under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e0f5698970, createdName=ms9000000591668568, createdTime=Wed Oct 26 16:43:17 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188819, encodeId=577f1188819fd, content=请问杂志Under consideration要多久才变under review呢，还是一直这样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Fri Jan 28 14:17:01 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898537, encodeId=662589853e72, content=请问这个杂志有under review.的状态吗？还是说一直是under consideration呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=558a5381281, createdName=ms7000002088020020, createdTime=Wed Nov 11 18:48:07 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209381, encodeId=f9d41209381d9, content=Under consideration 10多天没有变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcf094033, createdName=qlh80, createdTime=Thu Apr 07 21:50:28 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109521, encodeId=cb81210952132, content=投稿尽量选择一些稳定的期刊！不然后续风险还得自己承担！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=101c5653809, createdName=ms5000001132160057, createdTime=Mon Jan 09 15:13:13 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098055, encodeId=20f8209805579, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一个月不到小修，被医院预警准备撤稿了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e16453257, createdName=ms3000000976128588, createdTime=Wed Nov 02 15:12:55 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213542, encodeId=c49a1213542c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：癌症;药理;调查研究 经验分享：感觉还是挺容易的，不过也得看文章方向，感觉他们喜欢药物作用研究的，从投稿到录用不到一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Fri Apr 22 23:09:34 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196162, encodeId=a41f119616221, content=杂志对语言要求还蛮高的，内容没给我啥意见，语言修了两次。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Tue Feb 22 17:51:28 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925339, encodeId=82f892533950, content=审稿速度:1.0 | 投稿命中率:100.0 | 版面费用:900.0 偏重的研究方向：生信 经验分享：10月初接收，接收后说付款后三个月内给proof，3个月后发邮件问，说安排在二月第一期上线，上线前会收到proof，现在二月第一期已经上线了，依然没有收到proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c5f31644024, createdName=TitanAtlas, createdTime=Thu Feb 18 20:01:38 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803157, encodeId=315480315e6e, content=内部消息。这个杂志马上要完蛋。大家都别投了。否则是赔了夫人又折兵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2591613307, createdName=hgsge, createdTime=Sat Jul 18 00:28:40 CST 2020, time=2020-07-18, status=1, ipAttribution=)]

2021-02-18 TitanAtlas

审稿速度:1.0 | 投稿命中率:100.0 | 版面费用:900.0
偏重的研究方向：生信
经验分享：10月初接收，接收后说付款后三个月内给proof，3个月后发邮件问，说安排在二月第一期上线，上线前会收到proof，现在二月第一期已经上线了，依然没有收到proof。

137 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2096292, encodeId=90cc209629218, content=一个月了还在under consideration, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e0f5698970, createdName=ms9000000591668568, createdTime=Wed Oct 26 16:43:17 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188819, encodeId=577f1188819fd, content=请问杂志Under consideration要多久才变under review呢，还是一直这样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Fri Jan 28 14:17:01 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898537, encodeId=662589853e72, content=请问这个杂志有under review.的状态吗？还是说一直是under consideration呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=558a5381281, createdName=ms7000002088020020, createdTime=Wed Nov 11 18:48:07 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209381, encodeId=f9d41209381d9, content=Under consideration 10多天没有变化 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcf094033, createdName=qlh80, createdTime=Thu Apr 07 21:50:28 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109521, encodeId=cb81210952132, content=投稿尽量选择一些稳定的期刊！不然后续风险还得自己承担！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=101c5653809, createdName=ms5000001132160057, createdTime=Mon Jan 09 15:13:13 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098055, encodeId=20f8209805579, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：一个月不到小修，被医院预警准备撤稿了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80e16453257, createdName=ms3000000976128588, createdTime=Wed Nov 02 15:12:55 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213542, encodeId=c49a1213542c3, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：癌症;药理;调查研究 经验分享：感觉还是挺容易的，不过也得看文章方向，感觉他们喜欢药物作用研究的，从投稿到录用不到一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63ef6490901, createdName=ms7000000507856696, createdTime=Fri Apr 22 23:09:34 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196162, encodeId=a41f119616221, content=杂志对语言要求还蛮高的，内容没给我啥意见，语言修了两次。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88926481377, createdName=ms3000001949605315, createdTime=Tue Feb 22 17:51:28 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925339, encodeId=82f892533950, content=审稿速度:1.0 | 投稿命中率:100.0 | 版面费用:900.0 偏重的研究方向：生信 经验分享：10月初接收，接收后说付款后三个月内给proof，3个月后发邮件问，说安排在二月第一期上线，上线前会收到proof，现在二月第一期已经上线了，依然没有收到proof。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c5f31644024, createdName=TitanAtlas, createdTime=Thu Feb 18 20:01:38 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803157, encodeId=315480315e6e, content=内部消息。这个杂志马上要完蛋。大家都别投了。否则是赔了夫人又折兵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2591613307, createdName=hgsge, createdTime=Sat Jul 18 00:28:40 CST 2020, time=2020-07-18, status=1, ipAttribution=)]

2020-07-18 hgsge

内部消息。这个杂志马上要完蛋。大家都别投了。否则是赔了夫人又折兵

146 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务